这是一篇来自已证抗体库的有关小鼠 Cd40lg的综述,是根据45篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Cd40lg 抗体。
Cd40lg 同义词: CD154; CD40-L; Cd40l; HIGM1; IGM; IMD3; Ly-62; Ly62; T-BAM; TRAP; Tnfsf5; Tnlg8b; gp39

赛默飞世尔
仓鼠 单克隆(MR-1)
  • 流式细胞仪; 小鼠; 图 6a
赛默飞世尔 Cd40lg抗体(eBioscience, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 6a). J Immunol (2018) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 6a
赛默飞世尔 Cd40lg抗体(eBioscience, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 6a). J Immunol (2018) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 5b
赛默飞世尔 Cd40lg抗体(eBioscience, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 5b). Nat Commun (2017) ncbi
仓鼠 单克隆(MR-1)
  • 流式细胞仪; 小鼠; 图 5b
赛默飞世尔 Cd40lg抗体(eBioscience, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 5b). Nat Commun (2017) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Cd40lg抗体(eBioscience, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 2). BMC Immunol (2011) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Cd40lg抗体(eBiosciences, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 2). J Leukoc Biol (2007) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Cd40lg抗体(Caltag, MR1)被用于被用于流式细胞仪在小鼠样本上 (图 2). Int Immunol (2002) ncbi
仓鼠 单克隆(MR-1)
  • 抑制或激活实验; 小鼠; 图 1
  • 免疫印迹; 小鼠
赛默飞世尔 Cd40lg抗体(noco, MR1)被用于被用于抑制或激活实验在小鼠样本上 (图 1) 和 被用于免疫印迹在小鼠样本上. J Exp Med (1993) ncbi
仓鼠 单克隆(MR1)
  • 免疫细胞化学; African green monkey; 图 4
赛默飞世尔 Cd40lg抗体(noco, noca)被用于被用于免疫细胞化学在African green monkey样本上 (图 4). EMBO J (1992) ncbi
仓鼠 单克隆(MR1)
  • 酶联免疫吸附测定; 小鼠
赛默飞世尔 Cd40lg抗体(noco, noca)被用于被用于酶联免疫吸附测定在小鼠样本上. Proc Natl Acad Sci U S A (1992) ncbi
BioLegend
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 1:600; 图 2a
BioLegend Cd40lg抗体(Biolegend, MR1)被用于被用于流式细胞仪在小鼠样本上浓度为1:600 (图 2a). elife (2019) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 图 s2a
BioLegend Cd40lg抗体(Biolegend, 106513)被用于被用于流式细胞仪在小鼠样本上 (图 s2a). Nat Med (2018) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 1:400; 图 6e
BioLegend Cd40lg抗体(BioLegend, MR-1)被用于被用于流式细胞仪在小鼠样本上浓度为1:400 (图 6e). Nat Commun (2017) ncbi
大鼠 单克隆(RMM-1)
  • 流式细胞仪; 小鼠; 1:400; 图 2
BioLegend Cd40lg抗体(BioLegend, 406513)被用于被用于流式细胞仪在小鼠样本上浓度为1:400 (图 2). Immun Ageing (2015) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 4f
  • 免疫印迹; 大鼠; 1:500; 图 4f
艾博抗(上海)贸易有限公司 Cd40lg抗体(Abcam, ab2391)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4f) 和 被用于免疫印迹在大鼠样本上浓度为1:500 (图 4f). Sci Rep (2019) ncbi
domestic rabbit 单克隆(EP462E)
  • 免疫印迹; 小鼠; 1:1000; 图 6c
艾博抗(上海)贸易有限公司 Cd40lg抗体(Abcam, ab52750)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6c). Nat Commun (2018) ncbi
Bio X Cell
仓鼠 单克隆(MR-1)
  • 抑制或激活实验; 小鼠; 图 4a
Bio X Cell Cd40lg抗体(BioXCell, MR-1)被用于被用于抑制或激活实验在小鼠样本上 (图 4a). Science (2017) ncbi
仓鼠 单克隆(MR-1)
  • 流式细胞仪; 小鼠; 图 s1b
Bio X Cell Cd40lg抗体(BioXcell, MR-1)被用于被用于流式细胞仪在小鼠样本上 (图 s1b). Transplantation (2015) ncbi
碧迪BD
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 3b
碧迪BD Cd40lg抗体(BD, R6-60.2)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Front Immunol (2022) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 1:100; 图 7a, 7b, s19a
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 7a, 7b, s19a). Nat Commun (2022) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 1:200; 图 e2a
碧迪BD Cd40lg抗体(BD Pharmingen, II/41)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 e2a). EMBO Rep (2021) ncbi
大鼠 单克隆(II/41)
  • 酶联免疫吸附测定; 小鼠; 1:200; 图 6a
碧迪BD Cd40lg抗体(BD Bioscience, II/41)被用于被用于酶联免疫吸附测定在小鼠样本上浓度为1:200 (图 6a). J Allergy Clin Immunol (2021) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 1:200
碧迪BD Cd40lg抗体(BD Biosciences, 553406)被用于被用于流式细胞仪在小鼠样本上浓度为1:200. elife (2020) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 s15
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于流式细胞仪在小鼠样本上 (图 s15). Science (2019) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 1:20; 图 2f, 5d
碧迪BD Cd40lg抗体(BD Biosciences, 553658)被用于被用于流式细胞仪在小鼠样本上浓度为1:20 (图 2f, 5d). Nat Immunol (2019) ncbi
大鼠 单克隆(R6-60.2)
  • 其他; 小鼠; 图 2b
碧迪BD Cd40lg抗体(BD Biosciences, 553409)被用于被用于其他在小鼠样本上 (图 2b). Int Immunol (2019) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 1:800; 图 1e
碧迪BD Cd40lg抗体(BD, R6-60.2)被用于被用于流式细胞仪在小鼠样本上浓度为1:800 (图 1e). Science (2019) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 s2b
碧迪BD Cd40lg抗体(BD Biosciences, 553409)被用于被用于流式细胞仪在小鼠样本上 (图 s2b). Mol Cell (2018) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 图 2j, s3k
碧迪BD Cd40lg抗体(BD, 550676)被用于被用于流式细胞仪在小鼠样本上 (图 2j, s3k). Genes Dev (2018) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 1:50; 图 3h
碧迪BD Cd40lg抗体(BD Biosciences, 553658)被用于被用于流式细胞仪在小鼠样本上浓度为1:50 (图 3h). Nat Commun (2018) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Cd40lg抗体(BD Biosciences, 550881)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Cell (2018) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 图 e6b
碧迪BD Cd40lg抗体(BD, II/41)被用于被用于流式细胞仪在小鼠样本上 (图 e6b). Nature (2018) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 1:200; 图 s1d
  • 酶联免疫吸附测定; 小鼠; 1:1000
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s1d) 和 被用于酶联免疫吸附测定在小鼠样本上浓度为1:1000. Science (2017) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Cd40lg抗体(BD, 553409)被用于被用于流式细胞仪在小鼠样本上 (图 s1). PLoS ONE (2016) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 1:200; 图 S5e
碧迪BD Cd40lg抗体(BD, 552867)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 S5e). Nat Commun (2016) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 1c
碧迪BD Cd40lg抗体(BD Bioscience, R6-60.2)被用于被用于流式细胞仪在小鼠样本上 (图 1c). Front Immunol (2016) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Cd40lg抗体(BD Bioscience, R6-60.2)被用于被用于流式细胞仪在小鼠样本上 (图 1). Nat Commun (2016) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD Cd40lg抗体(BD Bioscience, R6-60.2)被用于被用于流式细胞仪在小鼠样本上 (图 3). elife (2016) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于流式细胞仪在小鼠样本上. PLoS Pathog (2015) ncbi
仓鼠 单克隆(MR1)
  • 流式细胞仪; 小鼠; 表 s1
碧迪BD Cd40lg抗体(BD Biosciences, MR1)被用于被用于流式细胞仪在小鼠样本上 (表 s1). Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 图 3A
碧迪BD Cd40lg抗体(BD, 553437)被用于被用于流式细胞仪在小鼠样本上 (图 3A). J Immunol (2015) ncbi
大鼠 单克隆(R6-60.2)
  • 其他; 小鼠; 图 3a
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于其他在小鼠样本上 (图 3a). J Immunol (2015) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠
碧迪BD Cd40lg抗体(BD Biosciences, R6-60.2)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠
碧迪BD Cd40lg抗体(BD Biosciences, II/41)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠
碧迪BD Cd40lg抗体(BD, R6-60.2)被用于被用于流式细胞仪在小鼠样本上. Mol Cell Biol (2014) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Cd40lg抗体(BD Pharmingen, II/41)被用于被用于流式细胞仪在小鼠样本上 (图 s1). PLoS ONE (2013) ncbi
大鼠 单克隆(R6-60.2)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD Cd40lg抗体(BD, 552867)被用于被用于流式细胞仪在小鼠样本上 (图 3). PLoS ONE (2013) ncbi
大鼠 单克隆(II/41)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD Cd40lg抗体(BD, 553437)被用于被用于流式细胞仪在小鼠样本上 (图 3). PLoS ONE (2013) ncbi
文章列表
  1. Erlandsson M, Erdogan S, Was xe9 n C, Andersson K, Silfversw xe4 rd S, Pullerits R, et al. IGF1R signalling is a guardian of self-tolerance restricting autoantibody production. Front Immunol. 2022;13:958206 pubmed 出版商
  2. Satofuka H, Abe S, Moriwaki T, Okada A, Kazuki K, Tanaka H, et al. Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci. Nat Commun. 2022;13:1841 pubmed 出版商
  3. Aslam M, Alemdehy M, Kwesi Maliepaard E, Muhaimin F, Caganova M, Pardieck I, et al. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. EMBO Rep. 2021;22:e51184 pubmed 出版商
  4. Castiello M, Bosticardo M, Sacchetti N, Calzoni E, Fontana E, Yamazaki Y, et al. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency. J Allergy Clin Immunol. 2021;147:309-320.e6 pubmed 出版商
  5. Monzon Casanova E, Matheson L, Tabbada K, Zarnack K, Smith C, Turner M. Polypyrimidine tract-binding proteins are essential for B cell development. elife. 2020;9: pubmed 出版商
  6. Saunders K, Wiehe K, Tian M, Acharya P, Bradley T, Alam S, et al. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science. 2019;366: pubmed 出版商
  7. Bagi Z, Couch Y, Brosková Z, Perez Balderas F, Yeo T, Davis S, et al. Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels. Sci Rep. 2019;9:15847 pubmed 出版商
  8. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed 出版商
  9. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed 出版商
  10. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed 出版商
  11. Grootjans J, Krupka N, Hosomi S, Matute J, Hanley T, Saveljeva S, et al. Epithelial endoplasmic reticulum stress orchestrates a protective IgA response. Science. 2019;363:993-998 pubmed 出版商
  12. Delgado Benito V, Rosen D, Wang Q, Gazumyan A, Pai J, Oliveira T, et al. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination. Mol Cell. 2018;72:636-649.e8 pubmed 出版商
  13. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed 出版商
  14. Kim S, Knight D, Jones L, Vervoort S, Ng A, Seymour J, et al. JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias. Genes Dev. 2018;32:849-864 pubmed 出版商
  15. Pircher J, Czermak T, Ehrlich A, Eberle C, Gaitzsch E, Margraf A, et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat Commun. 2018;9:1523 pubmed 出版商
  16. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed 出版商
  17. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed 出版商
  18. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed 出版商
  19. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed 出版商
  20. Singh M, Vianden C, Cantwell M, Dai Z, Xiao Z, Sharma M, et al. Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nat Commun. 2017;8:1447 pubmed 出版商
  21. Mayer C, Gazumyan A, Kara E, Gitlin A, Golijanin J, Viant C, et al. The microanatomic segregation of selection by apoptosis in the germinal center. Science. 2017;358: pubmed 出版商
  22. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed 出版商
  23. Martínez Martín N, Maldonado P, Gasparrini F, Frederico B, Aggarwal S, Gaya M, et al. A switch from canonical to noncanonical autophagy shapes B cell responses. Science. 2017;355:641-647 pubmed 出版商
  24. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed 出版商
  25. Bemark M, Hazanov H, Strömberg A, Komban R, Holmqvist J, Köster S, et al. Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization. Nat Commun. 2016;7:12698 pubmed 出版商
  26. Neyt K, GeurtsvanKessel C, Deswarte K, Hammad H, Lambrecht B. Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection. Front Immunol. 2016;7:312 pubmed 出版商
  27. Acharya M, Sokolovska A, Tam J, Conway K, Stefani C, Raso F, et al. αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun. 2016;7:10917 pubmed 出版商
  28. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed 出版商
  29. Sin S, Kim Y, Eason A, Dittmer D. KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice. PLoS Pathog. 2015;11:e1005135 pubmed 出版商
  30. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed 出版商
  31. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed 出版商
  32. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed 出版商
  33. Ouchida R, Lu Q, Liu J, Li Y, Chu Y, Tsubata T, et al. FcμR interacts and cooperates with the B cell receptor To promote B cell survival. J Immunol. 2015;194:3096-101 pubmed 出版商
  34. Matsuda T, Yanase S, Takaoka A, Maruyama M. The immunosenescence-related gene Zizimin2 is associated with early bone marrow B cell development and marginal zone B cell formation. Immun Ageing. 2015;12:1 pubmed 出版商
  35. Chiu Y, Lin I, Su S, Wang K, Yang S, Tsai D, et al. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol. 2014;193:2207-17 pubmed 出版商
  36. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed 出版商
  37. Schneppenheim J, Hüttl S, Mentrup T, Lüllmann Rauch R, Rothaug M, Engelke M, et al. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo. Mol Cell Biol. 2014;34:1398-411 pubmed 出版商
  38. Stoilova B, Kowenz Leutz E, Scheller M, Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBP? structure and post-translational modifications. PLoS ONE. 2013;8:e65169 pubmed 出版商
  39. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed 出版商
  40. Werner J, Busl E, Farkas S, Schlitt H, Geissler E, Hornung M. DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice. BMC Immunol. 2011;12:26 pubmed 出版商
  41. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  42. Futagawa T, Akiba H, Kodama T, Takeda K, Hosoda Y, Yagita H, et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol. 2002;14:275-86 pubmed
  43. Foy T, Shepherd D, Durie F, Aruffo A, Ledbetter J, Noelle R. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med. 1993;178:1567-75 pubmed
  44. Hollenbaugh D, Grosmaire L, Kullas C, Chalupny N, Braesch Andersen S, Noelle R, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992;11:4313-21 pubmed
  45. Noelle R, Roy M, Shepherd D, Stamenkovic I, Ledbetter J, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992;89:6550-4 pubmed